In this issue of Cell, Harris et al. reveal that high-molecular-weight soluble tau—rather than amyloid-beta—impairs burst firing in hippocampal neurons, providing a mechanistic link to cognitive decline in Alzheimer’s disease. This disruption, linked to CaV2.3 downregulation, highlights soluble tau as a key driver of neuronal dysfunction and a promising therapeutic target.